Relationship between plasma plasminogen activator inhibitor 1 and insulin resistance (Q33950656)

30 July 2017

1 reference

title

Relationship between plasma plasminogen activator inhibitor 1 and insulin resistance (English)

1 reference

30 July 2017

1 reference

1 reference

1 reference

Bastard JP

1

1 reference

PubMed ID

10867719

30 July 2017

Piéroni L

series ordinal

2

1 reference

PubMed ID

10867719

30 July 2017

Hainque B

series ordinal

3

1 reference

30 July 2017

1 May 2000

1 reference

Diabetes - Metabolism: Research and Reviews

30 July 2017

1 reference

30 July 2017

16

1 reference

30 July 2017

192-201

1 reference

30 July 2017

3

1 reference

The adipocyte and hemostatic balance in obesity: studies of PAI-1.

30 July 2017

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200005%2F06%2916%3A3%3C192%3A%3AAID-DMRR114%3E3.0.CO%3B2-G

Dependence of augmentation of arterial endothelial cell expression of plasminogen activator inhibitor type 1 by insulin on soluble factors released from vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200005%2F06%2916%3A3%3C192%3A%3AAID-DMRR114%3E3.0.CO%3B2-G

Unsaturated Fatty Acids Increase Plasminogen Activator Inhibitor-1 Expression in Endothelial Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200005%2F06%2916%3A3%3C192%3A%3AAID-DMRR114%3E3.0.CO%3B2-G

Elaboration of type-1 plasminogen activator inhibitor from adipocytes. A potential pathogenetic link between obesity and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200005%2F06%2916%3A3%3C192%3A%3AAID-DMRR114%3E3.0.CO%3B2-G

Inhibition of plasminogen activator inhibitor-1 activity results in promotion of endogenous thrombolysis and inhibition of thrombus extension in models of experimental thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200005%2F06%2916%3A3%3C192%3A%3AAID-DMRR114%3E3.0.CO%3B2-G

Plasminogen activator inhibitor-1 activity is independently related to both insulin sensitivity and serum triglycerides in 70-year-old men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200005%2F06%2916%3A3%3C192%3A%3AAID-DMRR114%3E3.0.CO%3B2-G

Hypertriglyceridemia and regulation of fibrinolytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200005%2F06%2916%3A3%3C192%3A%3AAID-DMRR114%3E3.0.CO%3B2-G

Gender differences in the relationships between plasma plasminogen activator inhibitor-1 activity and factors linked to the insulin resistance syndrome in essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200005%2F06%2916%3A3%3C192%3A%3AAID-DMRR114%3E3.0.CO%3B2-G

Plasminogen activator inhibitor-1, tissue-type plasminogen activator, and fibrinogen: Effect of dieting with or without exercise in overweight postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200005%2F06%2916%3A3%3C192%3A%3AAID-DMRR114%3E3.0.CO%3B2-G

PAI-1 produced ex vivo by human adipose tissue is relevant to PAI-1 blood level.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200005%2F06%2916%3A3%3C192%3A%3AAID-DMRR114%3E3.0.CO%3B2-G

Visceral fat accumulation is an important determinant of PAI-1 levels in young, nonobese men and women: modulation by cross-sex hormone administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200005%2F06%2916%3A3%3C192%3A%3AAID-DMRR114%3E3.0.CO%3B2-G

Five Frequent Polymorphisms of the PAI-1 Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200005%2F06%2916%3A3%3C192%3A%3AAID-DMRR114%3E3.0.CO%3B2-G

10.1002/1520-7560(200005/06)16:3<192::AID-DMRR114>3.0.CO;2-G

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

10867719